Press release

December 2018

Publication of the activity report and financial information for the first half-year (April – Sept. 2018)
12.03.2018

November 2018

Publication of the activity report and financial information for the first half-year on December 3, 2018
11.27.2018
Partial exercise of the over-allotment option and implementation of a liquidity agreement
11.05.2018

October 2018

Successful IPO of MedinCell
10.03.2018

September 2018

Teva to participate in MedinCell IPO
09.26.2018
Extension of the subscription period
09.25.2018
Launch of the Initial Public Offering
09.17.2018
Registration of the Document de base
09.05.2018

March 2018

EIB lends EUR 20m to MedinCell
03.22.2018

December 2017

MedinCell receives grant from the Bill & Melinda Gates Foundation
12.07.2017

October 2017

MedinCell announces investment by CM-CIC Innovation
10.19.2017